In accordance with the AMPS manual, proportions of clients with no change (< 0.3 logits), a clinically relevant increase (≥ 0.3 logits) or decrease (≥ − 0.3 logits) in AMPS ADL ability measures were identified [32]. Proportions of clients with no change (change < 0.5 SD) or a clinically relevant change (≥ 0.5 SD) on the ADL-I ability measures were identified [43] based on baseline sample SD. Baseline data (demographic, general health, and observation-based ADL ability; AMPS) of responders (i.e., clients achieving a clinically relevant increase in ADL ability) and non-responders, respectively, were explored in descriptive analyses. Finally, proportions of goals being rated in each of the five goal attainment levels were also identified. All proportions were presented in histograms.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.